Biomarkers in Neurodegenerative Diseases
This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future. The original research work and review articles published here highlight some...
محفوظ في:
| التنسيق: | Online |
|---|---|
| اللغة: | الإنجليزية |
| منشور في: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | ONIX_20230105_9783036557298_27 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1869526611435454464 |
|---|---|
| collection | Directory of Open Access Books |
| description | This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future. The original research work and review articles published here highlight some unique mechanisms underlying the most prevalent pathophysiological conditions affecting human health. Other areas covered in the book include emerging treatment options and correct diagnoses using different biochemical and imaging techniques. |
| format | Online |
| id | doab-20.500.12854ir-95798 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-957982024-03-31T13:09:48Z Biomarkers in Neurodegenerative Diseases Ghosh, Arnab Alzheimer’s disease amyloid beta hippocampus Kir channels K+ channels glioblastoma multiforme low-grade glioma astrocytoma recurrence multifocal growth mRNA expression MPS1 TTK therapy EDTA chelation therapy neurodegenerative diseases metal detoxification reactive oxygen species (ROS) neuroinflammation neurodegeneration cognitive dysfunction neurofibrillary tangles diagnosis methods biomarkers perinatal stress NURR1 inflammation late-onset diseases early life artificial neural network deep learning Parkinson’s disease atypical parkinsonian syndrome dopamine transporter SPECT β-Amyloid calpain Collapsin Response Mediator Protein-2 human-neuroblastoma SH-SY5Y cells Somatostatin-14 somatostatin receptor brain injury quinpirole dopamine D2 receptors glial cell autophagy mitophagy multiple sclerosis biomarker neurons astrocytes Alzheimer’s and Parkinson’s diseases fluid and imaging biomarkers amyloid-β and tau miRNA extracellular vesicles exosomes and ectosomes PET radiotracers radiolabeled molecules n/a thema EDItEUR::M Medicine and Nursing This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future. The original research work and review articles published here highlight some unique mechanisms underlying the most prevalent pathophysiological conditions affecting human health. Other areas covered in the book include emerging treatment options and correct diagnoses using different biochemical and imaging techniques. 2023-01-05T12:33:16Z 2023-01-05T12:33:16Z 2022 book ONIX_20230105_9783036557298_27 9783036557298 9783036557304 https://directory.doabooks.org/handle/20.500.12854/95798 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/6454 https://mdpi.com/books/pdfview/book/6454 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-5730-4 10.3390/books978-3-0365-5730-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036557298 9783036557304 190 Basel open access |
| spellingShingle | Alzheimer’s disease amyloid beta hippocampus Kir channels K+ channels glioblastoma multiforme low-grade glioma astrocytoma recurrence multifocal growth mRNA expression MPS1 TTK therapy EDTA chelation therapy neurodegenerative diseases metal detoxification reactive oxygen species (ROS) neuroinflammation neurodegeneration cognitive dysfunction neurofibrillary tangles diagnosis methods biomarkers perinatal stress NURR1 inflammation late-onset diseases early life artificial neural network deep learning Parkinson’s disease atypical parkinsonian syndrome dopamine transporter SPECT β-Amyloid calpain Collapsin Response Mediator Protein-2 human-neuroblastoma SH-SY5Y cells Somatostatin-14 somatostatin receptor brain injury quinpirole dopamine D2 receptors glial cell autophagy mitophagy multiple sclerosis biomarker neurons astrocytes Alzheimer’s and Parkinson’s diseases fluid and imaging biomarkers amyloid-β and tau miRNA extracellular vesicles exosomes and ectosomes PET radiotracers radiolabeled molecules n/a thema EDItEUR::M Medicine and Nursing Biomarkers in Neurodegenerative Diseases |
| title | Biomarkers in Neurodegenerative Diseases |
| title_full | Biomarkers in Neurodegenerative Diseases |
| title_fullStr | Biomarkers in Neurodegenerative Diseases |
| title_full_unstemmed | Biomarkers in Neurodegenerative Diseases |
| title_short | Biomarkers in Neurodegenerative Diseases |
| title_sort | biomarkers in neurodegenerative diseases |
| topic | Alzheimer’s disease amyloid beta hippocampus Kir channels K+ channels glioblastoma multiforme low-grade glioma astrocytoma recurrence multifocal growth mRNA expression MPS1 TTK therapy EDTA chelation therapy neurodegenerative diseases metal detoxification reactive oxygen species (ROS) neuroinflammation neurodegeneration cognitive dysfunction neurofibrillary tangles diagnosis methods biomarkers perinatal stress NURR1 inflammation late-onset diseases early life artificial neural network deep learning Parkinson’s disease atypical parkinsonian syndrome dopamine transporter SPECT β-Amyloid calpain Collapsin Response Mediator Protein-2 human-neuroblastoma SH-SY5Y cells Somatostatin-14 somatostatin receptor brain injury quinpirole dopamine D2 receptors glial cell autophagy mitophagy multiple sclerosis biomarker neurons astrocytes Alzheimer’s and Parkinson’s diseases fluid and imaging biomarkers amyloid-β and tau miRNA extracellular vesicles exosomes and ectosomes PET radiotracers radiolabeled molecules n/a thema EDItEUR::M Medicine and Nursing |
| topic_facet | Alzheimer’s disease amyloid beta hippocampus Kir channels K+ channels glioblastoma multiforme low-grade glioma astrocytoma recurrence multifocal growth mRNA expression MPS1 TTK therapy EDTA chelation therapy neurodegenerative diseases metal detoxification reactive oxygen species (ROS) neuroinflammation neurodegeneration cognitive dysfunction neurofibrillary tangles diagnosis methods biomarkers perinatal stress NURR1 inflammation late-onset diseases early life artificial neural network deep learning Parkinson’s disease atypical parkinsonian syndrome dopamine transporter SPECT β-Amyloid calpain Collapsin Response Mediator Protein-2 human-neuroblastoma SH-SY5Y cells Somatostatin-14 somatostatin receptor brain injury quinpirole dopamine D2 receptors glial cell autophagy mitophagy multiple sclerosis biomarker neurons astrocytes Alzheimer’s and Parkinson’s diseases fluid and imaging biomarkers amyloid-β and tau miRNA extracellular vesicles exosomes and ectosomes PET radiotracers radiolabeled molecules n/a thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20230105_9783036557298_27 |